Study of breast cancer subtypes in premenopausal women in Latin America
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at different biological “subtypes” of breast cancer in women who are still having periods. It helps researchers understand the cancer type and may guide more personalized care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman aged 20 to 45
- Live in the study area and have lived there for the past 3 years
- Have had at least one menstrual period in the last 12 months
- If you have breast cancer: your diagnosis must be a primary (first) breast cancer confirmed by lab tissue testing
- You must not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This trial supports Latina women who have higher breast cancer risk and face added barriers (like cost, transportation, safety, or isolation) to get recommended breast screening and genetic risk information. It aims to help you understand your risk and access care when it’s due.
This study follows women with breast cancer and certain lymphomas to understand long-term sexual and reproductive health. It may help researchers better support patients’ body changes and wellness over time during and after treatment.
This trial takes a close look at the proteins inside breast cancer cells, using samples from people with different subtypes. It aims to better understand how each type behaves, which could help guide future treatments.
This study tests a decision-making tool for Latina breast cancer survivors or those at high risk. It aims to help you make informed choices about breast surgery and reconstruction options.
This trial looks back at premenopausal women with early-stage, hormone-positive, HER2-negative breast cancer who had surgery and an Oncotype DX test, to see how different treatments affected their outcomes. If you fit this group, your past medical records could help researchers learn more about the best treatments.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.